Dr. Chuang and his co-Editor-in-Chief Dr. Huan Giap have put together an outstanding international-based group of editors. I have used the review articles as educational tools in the training of radiation oncology residents more than once now. Ultimately, I believe this journal will become ever more important to the dissemination of knowledge in cancer research, as well as an educational tool through its high caliber review articles.
Michael Story, PhD Vice-Chair, Department of Radiation Oncology; Professor and Chief, Division of Molecular Radiation Biology; Director, Genomics Shared Resource, Simmons Cancer Center, UT Southwestern Medical Center, USA
The editor and editorial office of Translational Andrology and Urology comply with the highest scientific standards. I am confident that the journal will establish a leading role in the years to come and therefore listing in the SCI will be a critical milestone.
Ashok Agarwal, PhD, HCLD Professor, Lerner College of Medicine, Case Western Reserve University; Director, Center for Reproductive Medicine; Director, Andrology Laboratory, Cleveland Clinic, Cleveland, USA
Notably, the editorial board has a long list of distinguished and well-respected scientists, academic scholars, experts, talented clinicians and specialists from the fields of Urology and Andrology worldwide.
Philip S. Li, MD Director, Microsurgical Research and Training, Associate Professor of Urology and Reproductive Medicine, Weill Cornell Medical College, New York, USA
The editorial office of the journal is highly motivated and proactively engaged in establishing the highest quality journal standards.
Pataje G.S. Prasanna, PhD Program Director, Radiation Research, Radiation Therapy Development Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA
There is strong, and in my experience, sometimes zealous peer review. The papers that are published are state of the art, unique and valuable contributions.
Barry Kogan, MD Chair of Urology, Albany Medical College, Albany, USA
I have been translational researcher in the field of particle beam therapy for more than 20 years, and highly value this journal as a multidisciplinary forum for researchers and clinicians active in translational cancer research.
Reinhard W. Schulte, MD, Dr. Med., Dipl. Phys., DABR Professor, Loma Linda University, Loma Linda University Medical Center, Loma Linda, USA